Delivery Order SPE2DB22D2206-SPE2DB24FGL92

Award Date 4/3/24
Potential Completion Date 4/4/24
Potential Value $4.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,711.64 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that enables Amerisourcebergen Drug Corp to provide a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,464.16 firm fixed-price delivery order is for MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,647.12 contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a specialty medical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,647.12 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a specialty pharmaceutical product. The award is associated with a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $4,647.12 firm fixed price delivery order is for the supply of Monovisc 88 mg/4 ml syringes, a specialized pharmaceutical product. This award is under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $4,647.12 firm fixed-price delivery order is for 4,564,437,255 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML product, with a completion date of April 30, 2024. The contract has no set-aside designation. Amerisourcebergen, a subsidiary of the larger Cencora, Inc. parent company, holds a significant...
This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $15,518.52 contract is for the provision of MONOVISC 88 MG/4 ML syringes. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. The IDC serves as the primary vehicle for Amerisourcebergen to...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $4,647.12 to provide MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. This delivery order was issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FGL92
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,647.12 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a specialty pharmaceutical product.

Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. No set-aside designation was used for this award.

Generated 7/3/24, 9:07 AM